Filter
802
Text search:
Multidrug
resistant
tuberculosis
Featured
96
188
Language
Document type
495
119
94
33
24
19
7
7
3
1
Countries / Regions
52
37
30
21
19
17
15
12
11
11
11
10
9
9
8
8
8
7
7
7
7
7
7
6
6
6
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
220
89
30
20
13
9
6
Toolboxes
410
84
54
19
16
12
12
11
11
9
8
7
6
6
6
6
5
4
4
2
1
Guidance for Orphans and Vulnerable Children Programs
Rapport de plaidoyer Mars 2011
303100 03/2011 E 1,000
An infection control programme puts together various practices which when used appropriately restrict the spread of infection
Accessed 25th March 2015
Reach the Unreached - FIND, TREAT, CURE TB, SAVE LIVES
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para
...
Eur Respir J 2014; 43: 24–35 | DOI: 10.1183/09031936.00113413
This year marked the beginning of the WHO biennium 2016-2017 action plan; this annual report highlights WHO’s key achievements in 2016
It also documents the extraordinary efforts by a broad coalition of government ministries, municipalities, international agencies, community groups, women’s or
...
This document contains a series of desk reviews for the eight ENGAGE-TB priority countries supported by the Global Fund (DRC, Kenya, Indonesia, Mozambique, Myanmar, Nigeria, Pakistan and Tanzania). The document provides a situation assessment and gap analysis about the state of community based TB ac
...
Evaluation report
December 2014
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
This implementation tool describes the recommended approaches for routine monitoring of toxicity integrated with the national monitoring and evaluation system and targeted approaches to monitoring toxicity to enable enhanced monitoring and reporting of treatment-limiting toxicity to support country
...
